z-logo
open-access-imgOpen Access
Vasopressin in vasoplegic shock: A systematic review
Author(s) -
Andrew Webb,
Mohamed O. Seisa,
Tarek Nayfeh,
Patrick M. Wieruszewski,
Scott D. Nei,
Nathan J. Smischney
Publication year - 2020
Publication title -
world journal of critical care medicine
Language(s) - English
Resource type - Journals
ISSN - 2220-3141
DOI - 10.5492/wjccm.v9.i5.88
Subject(s) - vasopressin , medicine , shock (circulatory) , cardiology
Vasoplegic shock is a challenging complication of cardiac surgery and is often resistant to conventional therapies for shock. Norepinephrine and epinephrine are standards of care for vasoplegic shock, but vasopressin has increasingly been used as a primary pressor in vasoplegic shock because of its unique pharmacology and lack of inotropic activity. It remains unclear whether vasopressin has distinct benefits over standard of care for patients with vasoplegic shock.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here